At the moment this isn’t possible, which is very annoying because often it’s one person that’s been asked to return a submission (usually to avoid rejecting them) that’s holding up closing the study. The only workaround is to blocklist participants individually which is a pain. Is there any good reason why it’s not possible to exclude studies that aren’t complete? Given that even “complete” studies can be reopened
1 Like